SNOA (MC $23 M) (Cash $13 M) Lots of Marketed Products

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
SNOA (MC $23 M) (Cash $13 M) Lots of Marketed Products

An SI Board Since August 2017

Posts	SubjectMarks	Bans	Symbol
11	2	0	SNOA

Emcee: BioHero	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
11	Here's one for study all = all feedback [if any] appreciated +++ [graphic]	Chartgod	-	September 6
10	Brazilian Dermatology Market Second Largest in the World Behind the United State	BioHero	-	10/31/2017
9	Great News out today ... Sonoma Pharmaceuticals Receives Brazilian Approvals to	BioHero	-	10/31/2017
8	new presentation ir.sonomapharma.com Sales Plan to Achieve Profitability •6-	BioHero	-	10/25/2017
7	Hey guys if you own shares of this low float stock then please put a high GTC s	BioHero	-	10/19/2017
6	Great buying opp here close at book value .. MA(50) at $5.30 and MA	BioHero	-	10/18/2017
5	This ultra low float stock is brutally undervalued which tradingjust a few pen	BioHero	-	10/18/2017
4	Looks like good entry point here. Looking for breakout at 5.93 for a run up to 6	hollyhunter	-	9/17/2017
3	New Fact Sheet .... files.shareholder.com Ø Pure play dermatology-focused	BioHero	-	8/24/2017
2	Minimum 7 Approvals expected within this year and new product launches in USA a	BioHero	-	8/18/2017
1	They got another FDA approval for a new Product 2 weeks ago for which there was	BioHero	-	8/15/2017

Go to reply# or date (mm/dd/yy):